What Happened
Dr. Donald Lyle Gates, who operates Scale Solutions weight-loss clinics in the Savannah, Georgia area, agreed to pay a $100,000 civil penalty after a DEA inspection found his offices could not account for controlled substances he was responsible for dispensing.
Gates operated weight-loss clinics in Savannah, Pooler, and Hinesville, Georgia, dispensing the prescription weight-loss drugs phentermine and phendimetrazine. DEA diversion investigators conducted on-site inspections and found the offices lacked complete and accurate records — including inventories and documentation of receipt, distribution, and dispensing — for the controlled substances registered to Gates.
Investigators also alleged that on more than one occasion, Gates failed to keep controlled substances at the locations registered with the DEA and instead transferred them to his home, outside the closed system the CSA uses to track controlled substances from manufacture to end user. Gates agreed to pay the $100,000 penalty and accept a two-year term of increased DEA oversight while retaining his registrations to dispense controlled substances.
What Went Wrong
- Inventory records didn't match what was on hand. A DEA audit — not an internal control — was what surfaced the recordkeeping gaps across multiple clinic locations.
- Controlled substances left the registered location. Moving stock to a private residence breaks the CSA's closed chain of custody and removes any ability to verify what happened to the drugs.
- No apparent internal audit caught the gap before DEA did. Recordkeeping failures spanning multiple clinic locations went uncorrected until an external inspection occurred.
How It Could Have Been Prevented
- Maintain current, reconcilable inventory logs for every controlled substance at each registered dispensing location, and reconcile them on a fixed schedule.
- Never store controlled substances at a location other than the one registered with the DEA, even temporarily.
- Conduct periodic self-audits modeled on DEA inspection criteria across all clinic locations under a single registrant.
- Assign clear accountability for recordkeeping at each site rather than leaving it to informal practice.
Related Guidance
- Regulatory Guide — CSA recordkeeping and registered-location requirements for dispensing practitioners.
- Diversion Prevention Checklist — Self-assessment covering inventory and recordkeeping controls.
- 15 Red Flags of Drug Diversion — Recordkeeping and inventory indicators of diversion risk.
- More Diversion Case Studies — Other recordkeeping-violation settlements.